Form 4: Adagio Medical Holdings CEO Acquires Stock Options
SEC Form 4 Filing
Adagio Medical Holdings CEO, Todd Usen, reports the acquisition of employee stock options.
Summary
- Todd Usen, CEO of Adagio Medical Holdings, reported a transaction on February 11, 2025, related to employee stock options.
- Usen acquired 1,820,567 employee stock options with an exercise price of $1.13.
- These options were granted under the company's 2024 Equity Incentive Plan.
- The options vest over a four-year period, with 25% vesting on December 13, 2025, and the remaining shares vesting in 36 equal monthly installments thereafter.
- The expiration date for these options is December 13, 2034.
Sentiment
Score: 7
Explanation: The document reflects a standard executive compensation practice, which is generally viewed neutrally to positively as it aligns management and shareholder interests. The sentiment is moderately positive as it indicates confidence in the company's future.
Positives
- The granting of stock options to the CEO aligns his interests with those of the shareholders.
- The vesting schedule encourages long-term commitment from the CEO.
Future Outlook
The document does not contain specific forward-looking statements beyond the vesting schedule of the options.
Industry Context
Stock options are a common form of executive compensation in the medical device industry, used to incentivize performance and align management interests with shareholder value.
Comparison to Industry Standards
- Executive compensation packages, including stock options, are common in publicly traded companies like Adagio Medical Holdings.
- The vesting schedule and exercise price are typical components of such packages, designed to incentivize long-term performance.
- Comparable companies in the medical device sector, such as Medtronic or Boston Scientific, also utilize stock options as part of their executive compensation plans.
Stakeholder Impact
- Shareholders may view the granting of stock options positively as it aligns the CEO's interests with the company's long-term success.
- Employees may see this as a positive sign of the company's commitment to its leadership.
Key Dates
| Date | Description |
|---|---|
| 02/11/2025 | Date of transaction: CEO acquired employee stock options. |
| 12/13/2025 | First vesting date: 25% of the options vest. |
| 12/13/2034 | Expiration date of the options. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.